Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-07-08
2008-07-08
Andres, Janet L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S232500, C514S320000, C514S392000, C514S429000, C514S453000, C514S459000
Reexamination Certificate
active
11111201
ABSTRACT:
The invention provides prodrugs of inhibitors of PI-3 kinase. The compounds are LY294002 and analogs thereof comprising a reversibly quaternized amine.
REFERENCES:
patent: 3937719 (1976-02-01), Sellstedt et al.
patent: 5116954 (1992-05-01), Briet et al.
patent: 5985856 (1999-11-01), Stella et al.
patent: WO 91/19707 (1991-12-01), None
patent: WO 01/53266 (2001-07-01), None
patent: WO 03/024949 (2003-03-01), None
Rogers et al Expert Opin. Ther. Targets (2005) 9(4) pp. 769-790.
Workman Nat. Biotech. vol. 24 No. 7 pp. 794-796 (2006).
Bantick, J., et al., “Synthesis of 2-Aminochromones, Studies on the Nucleophilic Displacement of Sulphinyl and Sulphonyl Groups in the 2-Position of 5,8-Dimethoxychromone,” J. Het. Chem., vol. 18, pp. 679-684 (1981).
Chiosis, G., et al., “LY294002-Geldanamycin Heterodimers as Selective Inhibitors of the PI3K and PI3K-related Family,” Bioorganic & Medicinal Chemistry Letters, vol. 11, pp. 909-913 (2001).
Vlahos, C., et al., “A Specific Inhibitor of Phosphatidylinositol 3-Kinase, 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)” Journal of Biological Chemistry, vol. 269, No. 7, pp. 5241-5248 (1994).
Walker, E., et al., “Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine,” Molecular Cell, vol. 6, pp. 909-919 (2000).
Wermuth, C., et al., “Designing Prodrugs and Bioprecursors I: Carrier Prodrugs,” The Practice of Medicinal Chemistry, Academic Press Limited, pp. 671-696 (1996).
PCT International Search Report for PCT/US2004/010399 dated Aug. 12, 2004.
Statement Accompanying Form PTO/SB/08B.
Durden Donald L.
Garlich Joseph R.
Patterson Mary
Su Jingdong
Suhr Robert G.
Andres Janet L.
Covington Raymond
Polsinelli Shalton Flanigan Suelthaus PC
Scott, Jr. Teddy C.
Semafore Pharmaceuticals, Inc.
LandOfFree
PI-3 kinase inhibitor prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PI-3 kinase inhibitor prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PI-3 kinase inhibitor prodrugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3950921